HC Wainwright Initiates Stemline Therapeutics At Buy By: Benzinga via Benzinga April 27, 2015 at 09:31 AM EDT In a report published Monday, H.C. Wainwright analysts initiated coverage of Stemline Therapeutics Inc (NASDAQ: STML) with a Buy rating ... Read More >> Related Stocks: Stemline Therapeutic